Symposium Speaker: Estee Cramer, MPH

Estee Cramer is a PhD candidate in Epidemiology at the University of Massachusetts Amherst School of Public Health & Health Sciences. Ms. Cramer earned her Bachelor of Arts in Biology and Master in Public Health with an emphasis in Global Health at Case Western Reserve University.

 

Recent Publications

  1. Mathis, SM, Webber, AE, León, TM, Murray, EL, Sun, M, White, LA, Brooks, LC, Green, A, Hu, AJ, Rosenfeld, R et al.. Title evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizations. Nat Commun 2024; 15 (1): 6289. PubMed PMID:39060259 PubMed Central PMC11282251.
  2. Lopez, VK, Cramer, EY, Pagano, R, Drake, JM, O'Dea, EB, Adee, M, Ayer, T, Chhatwal, J, Dalgic, OO, Ladd, MA et al.. Challenges of COVID-19 Case Forecasting in the US, 2020-2021. PLoS Comput Biol 2024; 20 (5): e1011200. PubMed PMID:38709852 PubMed Central PMC11098513.
  3. Cramer, EY, Nguyen, XQ, Hertz, JC, Nguyen, DV, Quang, HH, Mendenhall, IH, Lover, AA. Measuring effects of ivermectin-treated cattle on potential malaria vectors in Vietnam: A cluster-randomized trial. PLoS Negl Trop Dis 2024; 18 (4): e0012014. PubMed PMID:38683855 PubMed Central PMC11098492.
  4. Mathis, SM, Webber, AE, León, TM, Murray, EL, Sun, M, White, LA, Brooks, LC, Green, A, Hu, AJ, McDonald, DJ et al.. Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizations. medRxiv 2023; : . PubMed PMID:38168429 PubMed Central PMC10760285.
  5. Reich, NG, Wang, Y, Burns, M, Ergas, R, Cramer, EY, Ray, EL. Assessing the utility of COVID-19 case reports as a leading indicator for hospitalization forecasting in the United States. Epidemics 2023; 45 : 100728. PubMed PMID:37976681 PubMed Central PMC10871058.
  6. Cramer, EY, Bartlett, J, Chan, ER, Gaedigk, A, Ratsimbasoa, AC, Mehlotra, RK, Williams, SM, Zimmerman, PA. Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism. Pharmacogenomics 2023; 24 (11): 583-597. PubMed PMID:37551613 PubMed Central PMC10621762.
  7. Reich, NG, Wang, Y, Burns, M, Ergas, R, Cramer, EY, Ray, EL. Assessing the utility of COVID-19 case reports as a leading indicator for hospitalization forecasting in the United States. medRxiv 2023; : . PubMed PMID:36945396 PubMed Central PMC10029058.
  8. Cramer, EY, Snyder, T, Ravenhurst, J, Lover, AA. Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidance. BMC Public Health 2022; 22 (1): 1907. PubMed PMID:36224583 PubMed Central PMC9556138.
  9. Cramer, EY, Huang, Y, Wang, Y, Ray, EL, Cornell, M, Bracher, J, Brennen, A, Rivadeneira, AJC, Gerding, A, House, K et al.. The United States COVID-19 Forecast Hub dataset. Sci Data 2022; 9 (1): 462. PubMed PMID:35915104 PubMed Central PMC9342845.
  10. Ray, EL, Brooks, LC, Bien, J, Biggerstaff, M, Bosse, NI, Bracher, J, Cramer, EY, Funk, S, Gerding, A, Johansson, MA et al.. Comparing trained and untrained probabilistic ensemble forecasts of COVID-19 cases and deaths in the United States. Int J Forecast 2023; 39 (3): 1366-1383. PubMed PMID:35791416 PubMed Central PMC9247236.
Search PubMed

The Cramer Lab Website

Curriculum vitae